TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← All congress trades
← Congress trades
SB

Susan W. Brooks

U.S. House·IN·last disclosed 2020-04-27
Estimated book · cost basis
$250K
midpoint est. · $75.0K–$425K — not market value
18 holdings · $64.0K equity · $186K non-equity
Our verdict on their book · $-weighted, equity only
Buy37.5%Hold62.5%

38% of Susan W. Brooks's estimated equity book sits in stocks we independently rate Buy — biggest equity positions MSFT & MA. Their most recent disclosure: bought AMZN, filed 21d after the trade.

Disclosed trades
22
Buys · Sells
19 · 3
Median reporting lag
25d
avg 30d to disclose
Last disclosed
2020-04-27
Trade cadence · buys above, sells below · last 12 mo
Apr
Nov
Dec
Apr
Jun
Jan ’18
Apr
Jul
Jun
Sep
Jan ’20
Apr

What Susan W. Brooks owns now

Net book reconstructed from disclosed trades — cost basis, not market value · 18 holdings · since 2015

O
onS iD owner asset transaction type Date notification Date amount SP ZooMI, INC.non-equity
$15.0K–$50.0K13%
S
set transaction type Date notification Date amount SP onspira Therapeutics, Inc.non-equity
$15.0K–$50.0K13%
S
SP MYoTa, INC.non-equity
$15.0K–$50.0K13%
S
SP NexEos Diagnostics, Incnon-equity
$15.0K–$50.0K13%
S
sset transaction type Date notification Date amount SP alexar Therapeutics, Inc.non-equity
$2.00K–$30.0K6%
I
Investment SP Velicept Therapeutics, Inc.non-equity
$1.00K–$15.0K3%
E
et transaction type Date notification Date amount SP Velicept Therapeutics, Inc.non-equity
$1.00K–$15.0K3%
C
ctionS iD owner asset transaction type Date notification Date amount SP VELICEPTnon-equity
$1.00K–$15.0K3%
▸Show all 18 holdings
S
SP Velicept Therapeutics, Inc.non-equity
$1.00K–$15.0K3%
S
SP onspira Therapeutics, Incnon-equity
$1.00K–$15.0K3%
MS
MSFT
$1.00K–$15.0K3%
FV $430.00 · Jun '26Buy
MA
MA
$1.00K–$15.0K3%
FV $575.00 · Jun '26Buy
XO
XOM
$1.00K–$15.0K3%
FV $125.00 · Jul '26Hold
KO
KO
$1.00K–$15.0K3%
FV $85.00 · Jun '26Hold
AM
AMZN
$1.00K–$15.0K3%
FV $280.00 · Jun '26Buy
CV
CVX
$1.00K–$15.0K3%
Hold
VZ
VZ
$1.00K–$15.0K3%
FV $50.00 · Jun '26Hold
QC
QCOM
$1.00K–$15.0K3%
FV $200.00 · Jun '26Hold

Cost-basis estimate from disclosed ranges (midpoints), not market value · a * marks names sold beyond what we observed bought (size understated) · how we built this

What Susan W. Brooks did

22 disclosed trades

2020-04-27AMZNAmazon.com, Inc.Buy
$1.00K–$15.0K
21d lagtraded 2020-04-06PTR ↗
2020-04-27CVXIRA Chevron CorporationBuy
$1.00K–$15.0K
21d lagtraded 2020-04-06PTR ↗
2020-04-27KOIRA Coca-Cola CompanyBuy
$1.00K–$15.0K
21d lagtraded 2020-04-06PTR ↗
2020-04-27XOMIRA Exxon Mobil CorporationBuy
$1.00K–$15.0K
21d lagtraded 2020-04-06PTR ↗
2020-04-27MAIRA Mastercard IncorporatedBuy
$1.00K–$15.0K
21d lagtraded 2020-04-06PTR ↗
2020-04-27MSFTIRA Microsoft CorporationBuy
$1.00K–$15.0K
21d lagtraded 2020-04-06PTR ↗
2020-04-27QCOMIRA QuAlCOMM IncorporatedBuy
$1.00K–$15.0K
21d lagtraded 2020-04-06PTR ↗
2020-04-27VZIRA Verizon Communications Inc.Buy
$1.00K–$15.0K
21d lagtraded 2020-04-06PTR ↗
2020-02-27—onspira Therapeutics, IncSell
$15.0K–$50.0K
filed 50d latetraded 2020-01-08PTR ↗
2019-10-21—SP NexEos Diagnostics, IncBuy
$15.0K–$50.0K
26d lagtraded 2019-09-25PTR ↗
2019-06-25—SP onspira Therapeutics, IncBuy
$1.00K–$15.0K
22d lagtraded 2019-06-03PTR ↗
2018-07-20—SP Velicept Therapeutics, Inc.Buy
$1.00K–$15.0K
8d lagtraded 2018-07-12PTR ↗
2018-05-15—SP MYoTa, INC.Buy
$15.0K–$50.0K
33d lagtraded 2018-04-12PTR ↗
2018-02-06—ctionS iD owner asset transaction type Date notification Date amount SP VELICEPTBuy
$1.00K–$15.0K
28d lagtraded 2018-01-09PTR ↗
2017-07-17—set transaction type Date notification Date amount SP onspira Therapeutics, Inc.Buy
$15.0K–$50.0K
32d lagtraded 2017-06-15PTR ↗
2017-05-03—et transaction type Date notification Date amount SP Velicept Therapeutics, Inc.Buy
$1.00K–$15.0K
25d lagtraded 2017-04-08PTR ↗
2016-01-11—sset transaction type Date notification Date amount SP alexar Therapeutics, Inc.Buy
$1.00K–$15.0K
19d lagtraded 2015-12-23PTR ↗
2016-01-11—Investment SP CaSTLE CREEK INVESToRS, LLC - BUILDINg oNESell
$50.0K–$100K
31d lagtraded 2015-12-11PTR ↗
2016-01-11—Investment SP CaSTLE CREEK INVESToRS, LLC - BUILDINg TWoSell
$50.0K–$100K
31d lagtraded 2015-12-11PTR ↗
2016-01-11—Investment SP Velicept Therapeutics, Inc.Buy
$1.00K–$15.0K
filed 49d latetraded 2015-11-23PTR ↗
2015-05-14—onS iD owner asset transaction type Date notification Date amount SP ZooMI, INC.Buy
$15.0K–$50.0K
filed 107d latetraded 2015-01-27PTR ↗
2015-05-11—sset transaction type Date notification Date amount SP alexar Therapeutics, Inc.Buy
$1.00K–$15.0K
26d lagtraded 2015-04-15PTR ↗
How we built this

The portfolio is reconstructed from Susan W. Brooks's disclosed STOCK Act transactions, netting each asset's buy/sell amount ranges at their midpoints — a cost-basis estimate, not market value, and not a certified holdings statement.

Figures cover the household as disclosed (self, spouse & dependents). Amounts are STOCK Act ranges, never exact. Disclosures lag the trade by up to ~45 days. A * marks names sold beyond what we observed bought — the true position size is understated (a position held before our data window).

Long-held positions a member never trades within our data window aren't captured.

Our Buy/Hold/Sell verdict and fair value are our own SEC-grounded ratings of each stock — not a view on the member's trade, and not investment advice.

Source: U.S. House Clerk + U.S. Senate eFD (public records).